| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Decibel Therapeutics Inc (NASDAQ: DBTX)
DBTX Technical Analysis
3
| As on 9th Jun 2023 DBTX STOCK Price closed @ 4.41 and we RECOMMEND Buy for LONG-TERM with Stoploss of 3.63 & Buy for SHORT-TERM with Stoploss of 4.28 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DBTXSTOCK Price
| Open | 4.58 | Change | Price | % |
| High | 4.58 | 1 Day | 0.03 | 0.68 |
| Low | 4.29 | 1 Week | 0.37 | 9.16 |
| Close | 4.41 | 1 Month | 0.98 | 28.57 |
| Volume | 9371 | 1 Year | -0.16 | -3.50 |
| 52 Week High 5.61 | 52 Week Low 1.85 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| DBTX Daily Charts |
DBTX Intraday Charts |
Whats New @ Bazaartrend |
DBTX Free Analysis |
|
|
DBTX Important Levels Intraday
| RESISTANCE | 4.97 |
| RESISTANCE | 4.79 |
| RESISTANCE | 4.68 |
| RESISTANCE | 4.57 |
| SUPPORT | 4.25 |
| SUPPORT | 4.14 |
| SUPPORT | 4.03 |
| SUPPORT | 3.85 |
DBTX Forecast May 2024
| 4th UP Forecast | 6.76 |
| 3rd UP Forecast | 6.01 |
| 2nd UP Forecast | 5.54 |
| 1st UP Forecast | 5.07 |
| 1st DOWN Forecast | 3.75 |
| 2nd DOWN Forecast | 3.28 |
| 3rd DOWN Forecast | 2.81 |
| 4th DOWN Forecast | 2.06 |
DBTX Weekly Forecast
| 4th UP Forecast | 6.07 |
| 3rd UP Forecast | 5.54 |
| 2nd UP Forecast | 5.21 |
| 1st UP Forecast | 4.88 |
| 1st DOWN Forecast | 3.94 |
| 2nd DOWN Forecast | 3.61 |
| 3rd DOWN Forecast | 3.28 |
| 4th DOWN Forecast | 2.75 |
DBTX Forecast2024
| 4th UP Forecast | 12.45 |
| 3rd UP Forecast | 9.87 |
| 2nd UP Forecast | 8.28 |
| 1st UP Forecast | 6.68 |
| 1st DOWN Forecast | 2.14 |
| 2nd DOWN Forecast | 0.54 |
| 3rd DOWN Forecast | -1.05 |
| 4th DOWN Forecast | -3.63 |
Decibel Therapeutics Inc ( NASDAQ USA Symbol : DBTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DBTX Business Profile
Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for Congenital, Monogenic Hearing Loss designed to restore functional cells within the cochlea to address hearing disorders caused by single gene mutations; Gene Therapies for Hair Cell Regeneration designed to replace lost hair cells within the inner ear to address acquired hearing loss and balance disorders; and Otoprotection Therapeutic in clinical development to prevent hearing loss in cancer patients undergoing chemotherapy with cisplatin. The company's lead gene therapy product candidate is DB-OTO to provide hearing to individuals born with profound hearing loss due to mutation of the otoferlin gene. It is also developing DB-ATO, a gene therapy program designed to restore balance in patients with bilateral vestibulopathy by regenerating lost hair cells within the inner ear; and DB-020 for the prevention of cisplatin-induced hearing loss, which is in Phase 1b clinical trial. Decibel Therapeutics, Inc. has a strategic collaboration with Regeneron Pharmaceuticals, Inc. to develop gene therapies for monogenic forms of congenital hearing loss. The company was formerly known as Hearing Inc. and changed its name to Decibel Therapeutics, Inc. in April 2014. Decibel Therapeutics, Inc. was incorporated in 2013 and is headquartered in Boston, Massachusetts. Address: 1325 Boylston Street, Boston, MA, United States, 02215
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service